Tiny medical implants that can ferry drugs, cells, or other therapies safely to sites of disease are already seeing the light of day. Designing implantable devices that are ignored by the immune system can be a challenge, so we usually rely on materials that are naturally biocompatible. At MIT, researchers have discovered that the size and shape of implantable microparticles is also important as to whether the immune system will attack them.
Google’s co-founders may have downplayed that they’re interested in turning the tech giant into a healthcare company. But their company sure hasn’t been acting that way lately. While Apple has had some hiccups when it […]
Out of 91 of the world’s largest medical device companies, these 10 have had the best stock performance so far this year. One company, Teleflex Inc., is figuring out how to run super-lean in the […]
When a patient is diagnosed with a solid tumor cancer, one of the first options for treatment is often surgical removal of the tumor. But the biggest challenge for surgery as a treatment for cancer […]